JPH0256898B2 - - Google Patents
Info
- Publication number
- JPH0256898B2 JPH0256898B2 JP57148492A JP14849282A JPH0256898B2 JP H0256898 B2 JPH0256898 B2 JP H0256898B2 JP 57148492 A JP57148492 A JP 57148492A JP 14849282 A JP14849282 A JP 14849282A JP H0256898 B2 JPH0256898 B2 JP H0256898B2
- Authority
- JP
- Japan
- Prior art keywords
- blood
- ultrafiltrate
- chamber
- ultrafiltration
- gland
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004369 blood Anatomy 0.000 claims abstract description 74
- 239000008280 blood Substances 0.000 claims abstract description 74
- 239000012528 membrane Substances 0.000 claims abstract description 54
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 27
- 210000004907 gland Anatomy 0.000 claims abstract description 22
- 210000000056 organ Anatomy 0.000 claims abstract description 10
- 239000012982 microporous membrane Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 5
- 230000006461 physiological response Effects 0.000 abstract description 4
- 239000000470 constituent Substances 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 36
- 102000004877 Insulin Human genes 0.000 description 21
- 108090001061 Insulin Proteins 0.000 description 21
- 229940125396 insulin Drugs 0.000 description 21
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 18
- 239000011148 porous material Substances 0.000 description 17
- 238000009792 diffusion process Methods 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 239000000306 component Substances 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 239000012503 blood component Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 210000000496 pancreas Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000000762 glandular Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 210000003372 endocrine gland Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000005226 mechanical processes and functions Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000009103 reabsorption Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 241000287181 Sturnus vulgaris Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000002016 colloidosmotic effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000012229 microporous material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3475—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate with filtrate treatment agent in the same enclosure as the membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
- A61M1/3489—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents by biological cells, e.g. bioreactor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
- A61M1/3689—Chemical treatment by biological cells
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Biodiversity & Conservation Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- External Artificial Organs (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32109981A | 1981-11-13 | 1981-11-13 | |
| US321099 | 1981-11-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5883965A JPS5883965A (ja) | 1983-05-19 |
| JPH0256898B2 true JPH0256898B2 (US07754267-20100713-C00021.png) | 1990-12-03 |
Family
ID=23249174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57148492A Granted JPS5883965A (ja) | 1981-11-13 | 1982-08-25 | 限外濾過式ハイブリツド人工器官 |
Country Status (5)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0280798U (US07754267-20100713-C00021.png) * | 1988-12-13 | 1990-06-21 | ||
| WO2009031680A1 (ja) | 2007-09-07 | 2009-03-12 | The Nisshin Oillio Group, Ltd. | 1,3-ジ飽和-2-不飽和トリグリセリドの分別方法 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270192A (en) * | 1991-02-07 | 1993-12-14 | Monsanto Company | Biological artificial liver |
| KR100250630B1 (ko) * | 1992-02-07 | 2000-04-01 | 죤 에이치. 뷰센 | 생물학적 인공 간 |
| WO2001024849A1 (de) * | 1999-10-06 | 2001-04-12 | Membrana Gmbh | Membranmodul zur hemodiafiltration mit integrierter vor- oder nachverdünnung des bluts |
| US6776912B2 (en) | 1999-12-23 | 2004-08-17 | Membrana Gmbh | Hemodiafiltration system and method |
| GB2427556A (en) * | 2005-06-28 | 2007-01-03 | Martin Lister | Artificial liver |
| US8324780B2 (en) | 2008-03-21 | 2012-12-04 | Mitsubishi Electric Corporation | Automotive dynamoelectric machine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5119397A (US07754267-20100713-C00021.png) * | 1974-08-05 | 1976-02-16 | Ii Supiirubaagu Shiadoo | |
| JPS5610064A (en) * | 1979-06-30 | 1981-02-02 | Toshiba Corp | Two-phase dc commutatorless motor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3734851A (en) * | 1969-12-29 | 1973-05-22 | K Matsumura | Method and device for purifying blood |
| CA1027304A (en) * | 1973-06-06 | 1978-03-07 | Theodore E. Spielberg | Artificial gland structure |
| FR2268535B1 (US07754267-20100713-C00021.png) * | 1974-04-23 | 1976-12-17 | Rhone Poulenc Ind | |
| US4013564A (en) * | 1975-03-17 | 1977-03-22 | Takeda Chemical Industries, Ltd. | Multipurpose metabolic assist system |
| DE2851929A1 (de) * | 1978-12-01 | 1980-06-04 | Peter Weiss | Dialysator fuer kuenstliche nieren |
-
1982
- 1982-08-16 CA CA000409491A patent/CA1213404A/en not_active Expired
- 1982-08-25 JP JP57148492A patent/JPS5883965A/ja active Granted
- 1982-11-12 EP EP82306050A patent/EP0079781B1/en not_active Expired
- 1982-11-12 DE DE8282306050T patent/DE3271788D1/de not_active Expired
- 1982-11-12 AT AT82306050T patent/ATE20433T1/de not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5119397A (US07754267-20100713-C00021.png) * | 1974-08-05 | 1976-02-16 | Ii Supiirubaagu Shiadoo | |
| JPS5610064A (en) * | 1979-06-30 | 1981-02-02 | Toshiba Corp | Two-phase dc commutatorless motor |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0280798U (US07754267-20100713-C00021.png) * | 1988-12-13 | 1990-06-21 | ||
| WO2009031680A1 (ja) | 2007-09-07 | 2009-03-12 | The Nisshin Oillio Group, Ltd. | 1,3-ジ飽和-2-不飽和トリグリセリドの分別方法 |
| EP2388307A1 (en) | 2007-09-07 | 2011-11-23 | The Nisshin OilliO Group, Ltd. | Fractionation method of 1,3-disaturated-2-unsaturated triglyceride |
| EP2388306A1 (en) | 2007-09-07 | 2011-11-23 | The Nisshin OilliO Group, Ltd. | Fractionation method of 1,3-disaturated-2-unsaturated triglyceride |
| EP2399977A1 (en) | 2007-09-07 | 2011-12-28 | The Nisshin OilliO Group, Ltd. | Fractionation method of 1,3-disaturated-2-unsaturated triglyceride |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3271788D1 (en) | 1986-07-24 |
| JPS5883965A (ja) | 1983-05-19 |
| CA1213404A (en) | 1986-11-04 |
| EP0079781A2 (en) | 1983-05-25 |
| ATE20433T1 (de) | 1986-07-15 |
| EP0079781B1 (en) | 1986-06-18 |
| EP0079781A3 (en) | 1983-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6372482B1 (en) | Device and method for performing a biological modification of a fluid | |
| US6472200B1 (en) | Device and method for performing a biological modification of a fluid | |
| US5981211A (en) | Maintaining cells for an extended time by entrapment in a contracted matrix | |
| US5827729A (en) | Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue | |
| US6858146B1 (en) | Artificial liver apparatus and method | |
| US7985336B2 (en) | Systems, methods and devices relating to a cellularized nephron unit | |
| US5741334A (en) | Artificial pancreatic perfusion device | |
| US20030129736A1 (en) | Device and method for performing a biological modification of a fluid | |
| JPH0120866B2 (US07754267-20100713-C00021.png) | ||
| EP1387706A1 (en) | Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications | |
| WO1992007615A1 (en) | A bioartificial liver | |
| US20020052571A1 (en) | Artificial kidney and methods of using same | |
| JPH0256898B2 (US07754267-20100713-C00021.png) | ||
| FR2814468A1 (fr) | Dispositif servant de bioreacteur | |
| US4925555A (en) | Ultrafiltering hybrid artificial organ | |
| EP0984740A1 (en) | Artificial gut | |
| Colton et al. | Development of novel semipermeable tubular membranes for a hybrid artificial pancreas | |
| JPS609822B2 (ja) | 代謝型人工肝臓 | |
| EP2444478A1 (en) | Tubular body fluid mass exchange system and mass exchange device | |
| CA2201159A1 (en) | Artificial liver apparatus and method | |
| Sparks et al. | Some Present Directions In Research On Tissue Transplantation Chambers | |
| ZA200200544B (en) | A device and method for performing a biological modification of a fluid. |
